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RmtD 16S RNA Methylase in Epidemiologically Unrelated
SPM-1-Producing Pseudomonas aeruginosa
Isolates from Brazil
We read with interest the article by Doi et al. (2) suggest-
ing that the coproduction of the metallo--lactamase SPM-1
and the RmtD 16S RNA methylase is highly prevalent
among imipenem-resistant Pseudomonas aeruginosa isolates
from Brazil. SPM-1 is widespread among Brazilian carbap-
enem-resistant P. aeruginosa isolates, and isolates carrying
blaSPM-1 have been observed in distinct regions of this coun-
try (3). The majority of SPM-1-producing isolates belong to
a unique molecular clone identified by pulsed-field gel elec-
trophoresis and automated ribotyping (3). The findings of
Doi et al. (2) led us to test a very broad collection of
epidemiologically unrelated blaSPM-1-carrying P. aeruginosa
strains recovered from diverse Brazilian regions for the
presence of rmtD.
We evaluated 26 epidemiologically unrelated SPM-1-pro-
ducing P. aeruginosa clinical isolates collected from different
patients during 2002 in 10 Brazilian cities located in nine
states (Table 1). These isolates belonged to 16 different
ribogroups, and six isolates belonged to the major ribotype
spread throughout the country (ribotype 72-3). Screening
for rmtD was performed by PCR using the primers rmtD-F
(5-GAG CGA ACT GAA GGA AAA AC-3) and rmtD-R
(5-CAG CAC GTA AAA CAG CTC-3), which produce a
730-bp product. Amplicons were sequenced on both strands by
using the ABIPrism 377 system (Applied Biosystems, Foster
City, CA). The nucleotide sequences were analyzed using the
Lasergene software package (DNASTAR, Madison, WI),
and the sequences obtained were compared to sequences avail-
able over the Internet (http://www.ncbi.nlm.nih.gov/blast/Blast
.cgi).
Among the 26 isolates, rmtD was detected in only 4 (15.4%)
strains. This rate is much lower than the results obtained pre-
viously (51.0%), implying that the production of RmtD is not
prevalent among SPM-1-producing isolates with distinct ge-
netic backgrounds and/or from different geographic areas in
Brazil.
blaSPM-1 is different from other metallo--lactamase
genes that are carried in class 1 integrons also harboring
aminoglycoside resistance genes as part of other gene cas-
settes (5) in that blaSPM-1 is embedded in a distinct genetic
element (4) where the correlation of -lactam and amin-
oglycoside resistance is not as evident. However, many
SPM-1-producing isolates are resistant to other antimicro-
bial agents, including aminoglycosides. Recently, Carvalho
et al. (1) reported that all 13 SPM-1-producing P. aeruginosa
isolates found in another Brazilian state carried a class 1
integron, named In163, harboring two aminoglycoside resis-
tance genes, aacA4 and aadA7, showing that aminoglycoside
resistance among SPM-1-producing isolates can be also en-
coded by distinct resistance mechanisms other than the
RmtD 16S RNA methylase gene.
TABLE 1. Characteristics of the 26 epidemiologically unrelated SPM-1-producing P. aeruginosa clinical isolates from different regions
in Brazil
Isolate Ribotype City State Specimen typea Presence of rmtD
882 103-1 Belo Horizonte Minas Gerais SSSI 
883 97-7 Belo Horizonte Minas Gerais Tracheal aspirate 
889 104-6 Belo Horizonte Minas Gerais Tracheal aspirate 
894 104-6 Belo Horizonte Minas Gerais SSSI 
877 72-3 Brası´lia Distrito Federal Tracheal aspirate 
878 72-3 Curitiba Parana´ Urine 
893 72-3 Curitiba Parana´ Bronchoalveolar wash 
874 72-3 Fortaleza Ceara´ Urine 
875 82-5 Fortaleza Ceara´ CVC 
884 88-2 Joa˜o Pessoa Paraiba Wound drainage 
895 88-2 Joa˜o Pessoa Paraiba Tracheal aspirate 
871 77-1 Londrina Parana´ Tracheal aspirate 
870 71-5 Salvador Bahia Ear secretion 
876 79-8 Salvador Bahia CVC 
890 127-4 Sa˜o Luı´s Maranha˜o Urine 
892 129-4 Sa˜o Luı´s Maranha˜o CVC 
872 77-5 Santo Andre´ Sa˜o Paulo Gastrointestinal secretion 
873 77-8 Santo Andre´ Sa˜o Paulo Gastrointestinal secretion 
879 88-1 Sa˜o Paulo Sa˜o Paulo Blood culture 
880 87-2 Sa˜o Paulo Sa˜o Paulo SSSI 
881 88-2 Sa˜o Paulo Sa˜o Paulo Blood culture 
885 88-2 Sa˜o Paulo Sa˜o Paulo SSSI 
886 129-8 Sa˜o Paulo Sa˜o Paulo SSSI 
887 72-3 Sa˜o Paulo Sa˜o Paulo Urine 
888 88-2 Sa˜o Paulo Sa˜o Paulo Stool 
891 72-3 Sa˜o Paulo Sa˜o Paulo Urine 
a CVC, central venous catheter; SSSI, skin and soft structure infection.
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The isolates evaluated were collected during a study sponsored by
Fundac¸a˜o de Amparo a` Pesquisa do Estado de Sa˜o Paulo (FAPESP
research grant 2001/033497) and kindly provided by Professor Ana C.
Gales, M.D., Ph.D.
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Authors’ Reply
The foregoing letter by Castanheira et al. examined the
occurrence of rmtD in epidemiologically unrelated, SPM-1-
producing Pseudomonas aeruginosa isolated in various parts of
Brazil and provided valuable additional data on the epidemi-
ology of this novel gene. They reported a much lower incidence
of rmtD (15.4%) among their study isolates than among the
isolates in our previous report (51.0%) (1).
There may be several factors for the apparently discordant
results. First, the isolates in our study were collected mostly
from large tertiary hospitals in the Sa˜o Paulo metropolitan
area, where the antibiotic selection pressure may be higher
than the national average. Indeed, a significant number of
rmtD-positive isolates in our study were obtained from a large
tertiary hospital in Sa˜o Paulo. Second, all of the SPM-1-pro-
ducing isolates in our report belonged to a single epidemic
clone that coproduced RmtD. Third, the isolates in our study
were collected between 2005 and 2006, while those in the study
by Castanheira et al. were from 2002. Also, it would be inter-
esting to know how many of the isolates studied by Castanheira
et al. were actually resistant or highly resistant to aminoglyco-
sides, whereas the majority of our isolates were. Finally, we
found a number of imipenem-resistant isolates in different
clonal groups that produced RmtD but not SPM-1 (1).
Equivalent data from the authors may provide further in-
sight into the clinical impact of this phenomenon in Brazil at
the national level. Both the authors and we recently reported
identification of RmtD-producing Enterobacteriaceae in Brazil
(2, 3). We now thus need to keep vigilant eyes on the occur-
rence of rmtD not only in P. aeruginosa but also in Enterobac-
teriaceae.
REFERENCES
1. Doi, Y., A. C. Ghilardi, J. Adams, D. de Oliveira Garcia, and D. L. Paterson.
2007. High prevalence of metallo--lactamase and 16S rRNA methylase copro-
duction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.
Antimicrob. Agents Chemother. 51:3388–3390.
2. Fritsche, T. R., G. H. Miller, R. N. Jones, and E. S. Armstrong. 2007. Abstr.
47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-2053.
3. Yamane, K., F. Rossi, M. G. Barberino, J. M. Adams-Haduch, Y. Doi, and
D. L. Paterson. 2008. 16S ribosomal RNA methylase RmtD produced by
Klebsiella pneumoniae in Brazil. J. Antimicrob. Chemother. 61:746–747.
Yohei Doi*
Division of Infectious Diseases
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15213
Doroti de Oliveira Garcia
Instituto Adolfo Lutz
Sa˜o Paulo, Brazil
David L. Paterson
Royal Brisbane and Women’s Hospital
University of Queensland
Brisbane, Australia
*Phone: (412) 648-6401
Fax: (412) 648-6399
E-mail: doiy@dom.pitt.edu
1588 LETTERS TO THE EDITOR ANTIMICROB. AGENTS CHEMOTHER.
 o
n
 N
ovem
ber 4, 2015 by University of Queensland Library
http://aac.asm
.org/
D
ow
nloaded from
 
